Cao Z - Search Results

1

Clinical cure rate of inactive HBsAg carriers with HBsAg <200 IU/ml treated with pegylated interferon.

Li H, Liang S, Liu L, Zhou D, Liu Y, Zhang Y, Chen X, Zhang J, Cao Z. Li H, et al. Among authors: cao z. Front Immunol. 2022 Dec 23;13:1091786. doi: 10.3389/fimmu.2022.1091786. eCollection 2022. Front Immunol. 2022. PMID: 36618361 Free PMC article.

2

[Study on T cell subsets in HIV/AIDS patients].

Li HY, Cao ZH, Ji YX, Wu H, Chen XY. Li HY, et al. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008 Aug;22(4):284-6. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008. PMID: 19105345 Chinese.

3

Proliferation, but not interleukin 2 production, of Gag-specific CD8+ T cells is associated with low HIV viremia and high CD4 counts in HIV-1-infected Chinese individuals.

Li H, Chen X, Jin X, Liu Z, Huang X, Cao Z, Guo C, Dong T, Wu H. Li H, et al. Among authors: cao z. J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):1-8. doi: 10.1097/QAI.0b013e3181aeccdc. J Acquir Immune Defic Syndr. 2009. PMID: 19584740

4

[Relationship between liver pathology and clinical characters in HBV carriers].

Ma LN, He ZM, Cao ZH, Zhang YH, Chen XY. Ma LN, et al. Zhonghua Gan Zang Bing Za Zhi. 2010 Jun;18(6):433-6. doi: 10.3760/cma.j.issn.1007-3418.2010.06.009. Zhonghua Gan Zang Bing Za Zhi. 2010. PMID: 20587313 Chinese.

5

Potent hepatitis B surface antigen response to treatment of hepatitis-B-e-antigen-positive chronic hepatitis B with α-interferon plus a nucleos(t)ide analog.

Chen X, Cao Z, Liu Y, Zhang H, Zhang Y, Ma L, Jin Y, Yu H, Ma B, Zheng Y, Wu H. Chen X, et al. Among authors: cao z. J Gastroenterol Hepatol. 2012 Mar;27(3):481-6. doi: 10.1111/j.1440-1746.2011.06970.x. J Gastroenterol Hepatol. 2012. PMID: 22098411

6

[Efficacy of low-dose interferon therapy for treating chronic hepatitis C patients who cannot tolerate standard treatment].

Cao ZH, Liu YL, Zheng YH, Ji SD, Wang JL, Liao JH, Zhang CY, Chen XY. Cao ZH, et al. Zhonghua Gan Zang Bing Za Zhi. 2012 Jan;20(1):20-4. doi: 10.3760/cma.j.issn.1007-3418.2012.01.008. Zhonghua Gan Zang Bing Za Zhi. 2012. PMID: 22464701 Clinical Trial. Chinese.

7

Extended treatment with peginterferon α-2a in combination with lamivudine or adefovir for 96 weeks yields high rates of HBeAg and HBsAg seroconversion.

Cao ZH, Ma LN, Zhang HW, Liu YL, Chen XY. Cao ZH, et al. J Dig Dis. 2013 Aug;14(8):446-50. doi: 10.1111/1751-2980.12065. J Dig Dis. 2013. PMID: 23615131 Clinical Trial.

8

[Efficacy and safety of peginterferon alfa-2a (40 kd) plus adefovir for 96 weeks in HBeAg-negative chronic hepatitis B patients].

Cao ZH, Ma LN, Liu YL, Jin Y, He ZM, Lu JF, Zhang YH, Chen XY. Cao ZH, et al. Zhonghua Gan Zang Bing Za Zhi. 2013 Jul;21(7):498-501. doi: 10.3760/cma.j.issn.1007-3418.2013.07.006. Zhonghua Gan Zang Bing Za Zhi. 2013. PMID: 24074706 Clinical Trial. Chinese.

9

Bone marrow suppression or active proliferation? An analysis of neutropenia after pegylated interferon treatment of patients with chronic hepatitis C.

Liu YL, Du XF, Chen XY, Ma LN, Guo DD, Lu JF, Cao ZH, Zhang YH. Liu YL, et al. Scand J Infect Dis. 2013 Dec;45(12):939-43. doi: 10.3109/00365548.2013.835067. Epub 2013 Oct 3. Scand J Infect Dis. 2013. PMID: 24090457

10

[Designing efficacious treatment strategies to achieve sustained immunological control of hepatitis infection in HBeAg-positive patients].

Chen XY, Cao ZH. Chen XY, et al. Zhonghua Gan Zang Bing Za Zhi. 2013 Jul;21(7):484-7. Zhonghua Gan Zang Bing Za Zhi. 2013. PMID: 24298657 Chinese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,831 results

Search Page

Filters